Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/aCNvy5si2IY/267939.php
Monday 28 October 2013
Yeast, human stem cells drive discovery of new Parkinson's disease drug targets
Using a discovery platform whose components range from yeast cells to human stem cells, Whitehead Institute scientists have identified a novel Parkinson's disease drug target and a compound capable of repairing neurons derived from Parkinson's patients. The platform - whose effectiveness is described in dual papers published online this week in the journal Science - could accelerate the discovery of drug candidates that address the underlying pathology of Parkinson's and other neurodegenerative diseases. Today, no such drugs exist...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment